Galen — a privately owned pharmaceutical company — seeks partnerships and acquisitions to drive forward its growth ambitions and build on proud legacy

Not many companies in the pharmaceutical sector can say that they have kept growing and targeting growth through the pandemic, while maintaining the same commitment to their values, patients and employees.

But Galen — a privately-owned global pharmaceutical sales and marketing company and part of Northern Irish pharma success story Almac Group — can certainly make that claim. The company is pursuing an ambitious plan to expand across new territories and therapeutic areas via acquisition, with particular sights set on further expansion into the USA and Europe.

It was Galen’s growth ambitions — coupled with its legacy, patient-centric core products and real potential to build — that attracted Dennise Broderick (pictured) to take on the role of Managing Director and President about three years ago.